Clinical Advances in the Management of Melanoma
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: 15 April 2026 | Viewed by 828
Special Issue Editors
Interests: melanoma; surgical oncology; immuno-oncology
Special Issue Information
Dear Colleagues,
Melanoma management has undergone transformative clinical advances in recent years, driven by breakthroughs in targeted therapies and immunomodulation. This review highlights key innovations shaping contemporary treatment paradigms, including BRAF/MEK inhibitors for mutation-specific targeting, immune checkpoint inhibitors such as anti-PD-1/CTLA-4, and TIL adoptive cell therapy that have improved survival in advanced disease. As our understanding of the underlying genomic alterations that drive melanoma improves, there is increased interest in tailoring therapy regimens based on histologic and molecular subtypes. Emerging approaches such as oncolytic viruses, cancer vaccines, bispecific T-cell Engagers (BiTEs), bispecific antibodies, and combination regimens are discussed, with attention to their real-world efficacy and safety profiles. Additionally, we address challenges in treatment sequencing, the clinical utility of adjuvant and neoadjuvant strategies for stage III/IV resectable melanoma, resistance mechanisms, and biomarker and liquid-biopsy development to guide personalized decision-making. The integration of these innovations into multidisciplinary care models underscores the importance of tailored therapies in optimizing patient outcomes. By synthesizing recent trial data and expert consensus, this work provides a practical framework for clinicians navigating the rapidly evolving landscape of melanoma therapeutics.
Dr. Kelly M. Mahuron
Dr. Yan Xing
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma immunotherapy
- targeted therapy
- immune checkpoint inhibitors
- melanoma subtypes
- adjuvant treatment
- neoadjuvant treatment
- tumor-infiltrating lymphocytes (TILs) therapy
- combination therapy
- molecular profiling
- bi-omarker-driven therapy
- clinical decision-making
- liquid biopsy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
